vs

Side-by-side financial comparison of CABOT CORP (CBT) and OneMain Holdings, Inc. (OMF). Click either name above to swap in a different company.

OneMain Holdings, Inc. is the larger business by last-quarter revenue ($1.1B vs $849.0M, roughly 1.3× CABOT CORP). OneMain Holdings, Inc. runs the higher net margin — 18.7% vs 8.6%, a 10.1% gap on every dollar of revenue. On growth, OneMain Holdings, Inc. posted the faster year-over-year revenue change (8.3% vs -11.1%). Over the past eight quarters, OneMain Holdings, Inc.'s revenue compounded faster (10.4% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

OneMain Holdings, Inc. is an American financial services holding company headquartered in Evansville, Indiana, with central offices throughout the United States. The company wholly owns OneMain Finance Corporation and its subsidiaries, through which it operates in the consumer finance and insurance industries as OneMain Financial. Its business primarily focuses on providing personal loans and optional insurance products to customers with limited access to traditional lenders, such as banks an...

CBT vs OMF — Head-to-Head

Bigger by revenue
OMF
OMF
1.3× larger
OMF
$1.1B
$849.0M
CBT
Growing faster (revenue YoY)
OMF
OMF
+19.4% gap
OMF
8.3%
-11.1%
CBT
Higher net margin
OMF
OMF
10.1% more per $
OMF
18.7%
8.6%
CBT
Faster 2-yr revenue CAGR
OMF
OMF
Annualised
OMF
10.4%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBT
CBT
OMF
OMF
Revenue
$849.0M
$1.1B
Net Profit
$73.0M
$204.0M
Gross Margin
24.9%
Operating Margin
15.2%
22.8%
Net Margin
8.6%
18.7%
Revenue YoY
-11.1%
8.3%
Net Profit YoY
-21.5%
61.9%
EPS (diluted)
$1.37
$1.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
OMF
OMF
Q4 25
$849.0M
$1.1B
Q3 25
$899.0M
$1.1B
Q2 25
$923.0M
$1.0B
Q1 25
$936.0M
$996.0M
Q4 24
$955.0M
$1.0B
Q3 24
$1.0B
$981.0M
Q2 24
$1.0B
$922.0M
Q1 24
$1.0B
$896.0M
Net Profit
CBT
CBT
OMF
OMF
Q4 25
$73.0M
$204.0M
Q3 25
$43.0M
$199.0M
Q2 25
$101.0M
$167.0M
Q1 25
$94.0M
$213.0M
Q4 24
$93.0M
$126.0M
Q3 24
$137.0M
$157.0M
Q2 24
$109.0M
$71.0M
Q1 24
$84.0M
$155.0M
Gross Margin
CBT
CBT
OMF
OMF
Q4 25
24.9%
Q3 25
24.5%
Q2 25
26.4%
Q1 25
25.7%
Q4 24
24.6%
Q3 24
24.0%
Q2 24
25.2%
Q1 24
24.1%
Operating Margin
CBT
CBT
OMF
OMF
Q4 25
15.2%
22.8%
Q3 25
15.2%
24.5%
Q2 25
18.1%
20.9%
Q1 25
17.3%
27.6%
Q4 24
16.2%
16.3%
Q3 24
15.0%
21.1%
Q2 24
16.9%
10.0%
Q1 24
15.3%
22.8%
Net Margin
CBT
CBT
OMF
OMF
Q4 25
8.6%
18.7%
Q3 25
4.8%
18.6%
Q2 25
10.9%
16.3%
Q1 25
10.0%
21.4%
Q4 24
9.7%
12.5%
Q3 24
13.7%
16.0%
Q2 24
10.7%
7.7%
Q1 24
8.2%
17.3%
EPS (diluted)
CBT
CBT
OMF
OMF
Q4 25
$1.37
$1.71
Q3 25
$0.80
$1.67
Q2 25
$1.86
$1.40
Q1 25
$1.69
$1.78
Q4 24
$1.67
$1.05
Q3 24
$2.41
$1.31
Q2 24
$1.94
$0.59
Q1 24
$1.49
$1.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
OMF
OMF
Cash + ST InvestmentsLiquidity on hand
$230.0M
$914.0M
Total DebtLower is stronger
$22.7B
Stockholders' EquityBook value
$1.6B
$3.4B
Total Assets
$3.8B
$27.4B
Debt / EquityLower = less leverage
6.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
OMF
OMF
Q4 25
$230.0M
$914.0M
Q3 25
$258.0M
$658.0M
Q2 25
$239.0M
$769.0M
Q1 25
$213.0M
$627.0M
Q4 24
$183.0M
$458.0M
Q3 24
$223.0M
$577.0M
Q2 24
$197.0M
$667.0M
Q1 24
$206.0M
$831.0M
Total Debt
CBT
CBT
OMF
OMF
Q4 25
$22.7B
Q3 25
$1.1B
$22.3B
Q2 25
$22.1B
Q1 25
$21.5B
Q4 24
$21.4B
Q3 24
$1.1B
$21.1B
Q2 24
$20.7B
Q1 24
$19.5B
Stockholders' Equity
CBT
CBT
OMF
OMF
Q4 25
$1.6B
$3.4B
Q3 25
$1.6B
$3.4B
Q2 25
$1.5B
$3.3B
Q1 25
$1.4B
$3.3B
Q4 24
$1.4B
$3.2B
Q3 24
$1.4B
$3.2B
Q2 24
$1.3B
$3.2B
Q1 24
$1.4B
$3.2B
Total Assets
CBT
CBT
OMF
OMF
Q4 25
$3.8B
$27.4B
Q3 25
$3.8B
$27.0B
Q2 25
$3.8B
$26.6B
Q1 25
$3.8B
$26.0B
Q4 24
$3.6B
$25.9B
Q3 24
$3.7B
$25.6B
Q2 24
$3.6B
$25.1B
Q1 24
$3.6B
$23.9B
Debt / Equity
CBT
CBT
OMF
OMF
Q4 25
6.67×
Q3 25
0.70×
6.61×
Q2 25
6.63×
Q1 25
6.55×
Q4 24
6.72×
Q3 24
0.75×
6.59×
Q2 24
6.56×
Q1 24
6.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
OMF
OMF
Operating Cash FlowLast quarter
$126.0M
$865.0M
Free Cash FlowOCF − Capex
$57.0M
FCF MarginFCF / Revenue
6.7%
Capex IntensityCapex / Revenue
8.1%
Cash ConversionOCF / Net Profit
1.73×
4.24×
TTM Free Cash FlowTrailing 4 quarters
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
OMF
OMF
Q4 25
$126.0M
$865.0M
Q3 25
$219.0M
$828.0M
Q2 25
$249.0M
$774.0M
Q1 25
$73.0M
$665.0M
Q4 24
$124.0M
$752.0M
Q3 24
$204.0M
$677.0M
Q2 24
$207.0M
$712.0M
Q1 24
$176.0M
$558.0M
Free Cash Flow
CBT
CBT
OMF
OMF
Q4 25
$57.0M
Q3 25
$155.0M
Q2 25
$188.0M
Q1 25
$1.0M
Q4 24
$47.0M
Q3 24
$112.0M
Q2 24
$155.0M
Q1 24
$133.0M
FCF Margin
CBT
CBT
OMF
OMF
Q4 25
6.7%
Q3 25
17.2%
Q2 25
20.4%
Q1 25
0.1%
Q4 24
4.9%
Q3 24
11.2%
Q2 24
15.3%
Q1 24
13.1%
Capex Intensity
CBT
CBT
OMF
OMF
Q4 25
8.1%
Q3 25
7.1%
Q2 25
6.6%
Q1 25
7.7%
Q4 24
8.1%
Q3 24
9.2%
Q2 24
5.1%
Q1 24
4.2%
Cash Conversion
CBT
CBT
OMF
OMF
Q4 25
1.73×
4.24×
Q3 25
5.09×
4.16×
Q2 25
2.47×
4.63×
Q1 25
0.78×
3.12×
Q4 24
1.33×
5.97×
Q3 24
1.49×
4.31×
Q2 24
1.90×
10.03×
Q1 24
2.10×
3.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

OMF
OMF

Segment breakdown not available.

Related Comparisons